JPRN-UMIN000003917招募中2 期
Randomised phase 2 trial of hepatic arterial chemotherapy with cisplatin and 5-FU versus sorafenib in patients with advanced unresectable hepatocellulare carcinoma - Evaluation of clinical effects of NFP therapy and sorafenib for advanced HCC
Kurume University, School od Medicine Department of Medicine, Division of Gastroenterology0 个研究点目标入组 80 人开始时间: 2010年7月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) extrahepatic metastasis 2) pregnant woman 3) drug allergy
研究者
相似试验
招募中
2 期
Cohort phase 2 study of hepatic arterial chemotherapy with cisplatin and 5-FU, and sorafenib in patients with advanced unresectable hepatocellular carcinomaunresectable advanced hepatocellular carcinomaJPRN-UMIN000004022Kurume University, School of Medicine, Division of Gastroenterology80
已完成
1 期
A phase 1 trial of hepatic arterial infusion chemotherapy with high dose cisplatin and 5-fluorouracil for unresectable advanced and recurrent hepatocellular carcinomaJPRN-UMIN000015101Keio University, School of medicine, Department of Surgery18
已完成
2 期
A phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosisJPRN-UMIN000000488Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital25
已完成
不适用
Clinical trial of hepatic arterial infusion chemotherapy with multidrug resistance-associated protein 3-derived peptide for hepatocellular carcinomaHepatocellular carcinoma (HCC)JPRN-UMIN000005678Department of Gastroenterology, Kanazawa University Hospital12
已完成
1 期
A phase I,II trial of hepatic arterial infusion chemotherapy with cisplatin and 5-fluorouracil for unresectable advanced hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000013734Sapporo Medical University School of Medicine28